1
|
McLaughlin M, Amaya A, Klevens M, O'Cleirigh C, Batchelder A. A Review of Factors Associated with Age of First Injection. J Psychoactive Drugs 2020; 52:412-420. [PMID: 32795151 PMCID: PMC7704573 DOI: 10.1080/02791072.2020.1804648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 05/14/2020] [Accepted: 06/01/2020] [Indexed: 10/23/2022]
Abstract
Injection drug use (IDU) is of increasing public health concern in the United States. Misuse of and addiction to opioids has contributed to declining life expectancies and rebounding risk of HIV and HCV acquisition among people who inject drugs. While some effective treatment strategies for individuals with substance use disorders have been established, effective interventions to prevent IDU require greater tailoring to subpopulations and social contexts. To better understand contextual variables associated with initiation of IDU, we conducted a narrative review of the existing literature that assessed correlates of age of first injection. We found sixteen studies that met our inclusion criteria. Across studies, later IDU initiation was associated with being African American and female, while early initiation was associated with earlier illicit substance use, childhood trauma, and incarceration. We also found that early initiation was associated with riskier substance-using behaviors, though the findings were mixed with respect to differences between early and late initiates in infectious disease prevalence. These correlates of age of first injection can potentially inform tailored injection prevention strategies. By identifying the features and behaviors of relevant subpopulations before they inject, interventions to prevent IDU could become more effective.
Collapse
Affiliation(s)
- Matthew McLaughlin
- Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA
| | - Andres Amaya
- The Fenway Institute, Fenway Health , Boston, MA, USA
| | - Monina Klevens
- Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health , Boston, MA, USA
| | - Conall O'Cleirigh
- Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA
- The Fenway Institute, Fenway Health , Boston, MA, USA
- Harvard Medical School, Harvard University , Boston, MA, USA
| | - Abigail Batchelder
- Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA
- The Fenway Institute, Fenway Health , Boston, MA, USA
- Harvard Medical School, Harvard University , Boston, MA, USA
| |
Collapse
|
2
|
Hines LA, Trickey A, Leung J, Larney S, Peacock A, Degenhardt L, Colledge S, Hickman M, Grebely J, Cunningham EB, Stone J, Dumchev K, Griffiths P, Vickerman P, Mattick RP, Lynskey M. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis. Lancet Glob Health 2020; 8:e76-e91. [PMID: 31839143 PMCID: PMC7024964 DOI: 10.1016/s2214-109x(19)30462-0] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Revised: 10/07/2019] [Accepted: 10/16/2019] [Indexed: 12/11/2022]
Abstract
BACKGROUND Globally, an estimated 15·6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the association between injecting drug use (IDU) in young people and rates of injecting and sexual risk behaviours at the country level. METHODS We derived data from a previously published global systematic review done in April, 2016 (and updated in June, 2017) on the percentage of young PWID, duration of IDU, average age of PWID, average age at IDU initiation, and the percentage of PWID reporting sexual and injecting risk behaviours. We also derived national development indicators from World Bank data. We estimated the percentage of young PWID for each country, using a random-effects meta-analysis (DerSimonian-Laird methodology) and generated pooled regional and global estimates for all indicators of IDU in young people. We used univariable and multivariable generalised linear models to test for associations between the age indicators and country urban population growth, youth unemployment percentage, the percentage of PWID who are female, the percentage of the general population aged 15-24 years, Gini coefficient, opioid substitution therapy coverage (per PWID per year), gross domestic product (GDP) per capita (US$1000), and sexual and injecting risk behaviours. FINDINGS In the original systematic review, data on age of PWID was reported in 741 studies across 93 countries. Globally, 25·3% (95% uncertainty interval [UI] 19·6-31·8) of PWID were aged 25 years or younger. The highest percentage of young PWID resided in eastern Europe (43·4%, 95% UI 39·4-47·4), and the lowest percentage resided in the Middle East and north Africa (6·9%, 5·1-8·8). At the country level, in multivariable analysis higher GDP was associated with longer median injecting duration (0·11 years per $1000 GDP increase, 95% CI 0·04-0·18; p=0·002), and older median age of PWID (0·13 years per $1000 increase, 0·06-0·20; p<0·0001). Urban population growth was associated with higher age at IDU initiation (1·40 years per annual percentage change, 0·41-2·40). No associations were identified between indicators of IDU in young people and youth unemployment, Gini coefficient, or opioid substitution therapy coverage provision at the country level. No associations were identified between injecting and sexual risk behaviours and age of PWID. INTERPRETATION Variation in the age profile of PWID was associated with GDP and urbanisation. Regions with the highest prevalence of young PWID (aged ≤25 years) had low coverage of interventions to prevent the spread of blood-borne viruses. Data quality highlights the need for improvements in monitoring of PWID populations. FUNDING Australian National Drug and Alcohol Research Centre, Australian National Health and Medical Research Council, Open Society Foundation, WHO, the Global Fund, UNAIDS, National Institute for Health Research Health Protection Research Unit for Evaluation of Interventions, Wellcome Trust.
Collapse
Affiliation(s)
- Lindsey A Hines
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
| | - Adam Trickey
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - Janni Leung
- National Drug and Alcohol Research Centre, Sydney, NSW, Australia
| | - Sarah Larney
- National Drug and Alcohol Research Centre, Sydney, NSW, Australia
| | - Amy Peacock
- National Drug and Alcohol Research Centre, Sydney, NSW, Australia
| | | | | | - Matthew Hickman
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - Jason Grebely
- Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia
| | - Evan B Cunningham
- Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia
| | - Jack Stone
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | | | - Paul Griffiths
- European Monitoring Centre on Drugs and Drug Addiction, Lisbon, Portugal
| | - Peter Vickerman
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | | | - Michael Lynskey
- National Addiction Centre, King's College London, London, UK
| |
Collapse
|
3
|
Goldman-Hasbun J, Nosova E, DeBeck K, Dahlby L, Kerr T. Food insufficiency is associated with depression among street-involved youth in a Canadian setting. Public Health Nutr 2019; 22:115-121. [PMID: 30305193 PMCID: PMC7498245 DOI: 10.1017/s1368980018002574] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2017] [Revised: 07/23/2018] [Accepted: 09/03/2018] [Indexed: 11/07/2022]
Abstract
OBJECTIVE Food insufficiency, defined by the experience of hunger, is known to be prevalent and a source of health-related harm among-street involved youth, but little is known about its relationship with depression in this population. Therefore, we sought to assess the association between food insufficiency and symptoms of depression among a cohort of street-involved youth. DESIGN Multivariable logistic regression was used to assess the relationship between food insufficiency, defined as being hungry but not having enough money to buy food, and depression as measured by the Center for Epidemiological Studies Depression (CES-D) scale. SETTING Data from April 2006 to November 2013 were derived from the At-Risk Youth Study (ARYS), a prospective cohort of street-involved youth who use illicit drugs in Vancouver, Canada. SUBJECTS There were 1066 street-involved youth enrolled in the study, including 340 (31·9 %) females. RESULTS Of 1066 youth enrolled in the study, 724 (67·9 %) reported some food insufficiency and 565 (53·0 %) met criteria for depression. Compared with youth who did not report food insufficiency, those who reported often experiencing food insufficiency had a higher likelihood of reporting depression (adjusted OR=2·52; 95 % CI 1·74, 3·67), as did those who reported sometimes experiencing food insufficiency (adjusted OR=1·99; 95 % CI 1·47, 2·70). CONCLUSIONS Food insufficiency was prevalent and associated in a dose-dependent trend with symptoms of depression among street-involved youth in our setting. Findings highlight the need to address the nutritional and mental health needs of youth and identify pathways by which food insufficiency may contribute to depression among vulnerable populations.
Collapse
Affiliation(s)
- Julia Goldman-Hasbun
- British Columbia Centre on Substance Use, 400–1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada
| | - Ekaterina Nosova
- British Columbia Centre on Substance Use, 400–1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada
| | - Kora DeBeck
- British Columbia Centre on Substance Use, 400–1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada
- School of Public Policy, Simon Fraser University, Vancouver, BC, Canada
| | - Lucia Dahlby
- British Columbia Centre on Substance Use, 400–1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada
| | - Thomas Kerr
- British Columbia Centre on Substance Use, 400–1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada
- Department of Medicine, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|